ArticleCureus2025
Assessing and Addressing Medical Residents' Knowledge Gaps in the Screening and Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease, Obesity, and Metabolic Syndrome: A Quality Improvement Project.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is the most common liver disease globally. Its rapid rise in prevalence parallels that of associated metabolic syndromes, highlighting the need for physicians well-trained in the evaluation and management of these conditions. While medical school and residency education touch on these topics, curricula often fail to address them in an adequate or longitudinal manner, leading to knowledge gaps in practice. Targeted lectures can reinforce key concepts and equip residents to manage these conditions appropriately. As such, this quality improvement study aimed to assess and enhance internal medicine residents' confidence and understanding of MASLD, obesity, and metabolic syndrome management through a targeted educational intervention. Methods We integrated a structured lecture, "Obesity/Metabolic Syndrome and MASLD: The Role of the Internist," into a Wednesday School didactic series between January 8, 2025 and February 26, 2025. Internal medicine residents attended one session each and completed pre- and post-surveys assessing confidence and knowledge in screening, risk stratification, and treatment of obesity and MASLD. Confidence was rated using four-point Likert scales, and data were visualized using stacked column charts. Participants indicated prior training through open-ended responses. Knowledge was evaluated using paired multiple-choice quizzes on the pre- and post-surveys, and scores were analyzed with paired t-tests to determine significance. Results Of 125 participants, 111 residents (88.8%) completed both surveys and were included in the final analysis. Confidence strongly improved across three key domains, as initially only 39.6% (n = 44), 27.9% (n = 31), and 25.2% (n = 28) of residents reported feeling "Moderately comfortable" or "Very comfortable" in managing obesity, anti-obesity medications, and MASLD, respectively. After the sessions, confidence in these realms rose to 94.6% (n = 105), 91.9% (n = 102), and 91.0% (n = 101). This increase in self-reported confidence was supported by significantly higher quiz scores after the lecture, rising from 73.9 ± 33.6 to 89.6 ± 22.5 (p < 0.001). Residents with higher baseline confidence often received prior exposure to MASLD education through conferences or clinical rotations. Qualitative feedback highlighted the relevance of the lecture and requested further instruction on pharmacologic management and institution-specific patient care pathways. Conclusion Targeted, lecture-based education can effectively improve internal medicine residents' confidence and knowledge in evaluating and managing MASLD, obesity, and metabolic syndromes. Thus, integrating these interventions into residency curriculum can fill knowledge gaps and strengthen resident preparedness to address the rising burden of metabolic disease. Future directions should explore longitudinal reinforcement through multiple stages of medical training, as well as implementation in other institutions to assess clinical impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.